Affective Speech Recognition Clinical Biomarker Effects of a Novel Vasopressin 1a Receptor Antagonist Vs Placebo in Adult Autism

被引：0
|
作者：
Hollander, Eric [1 ]
Rubido, Marta del Valle [2 ]
Khwaja, Omar [3 ]
Squassante, Lisa [4 ]
Ferretti, Casara J. [1 ]
Taylor, Bonnie P. [1 ]
Berlin, Gregory [1 ]
Noone, Rachel [1 ]
Antar, Laura [1 ]
McCracken, James [5 ]
Scahill, Lawrence [6 ]
Shic, Frederick [7 ]
Umbricht, Daniel [3 ]
机构：
[1] Univ Hosp Albert Einstein CoM, Montefiore Med Ctr, Bronx, NY USA
[2] Roche, CNS Translat Med Grp, Basel, Switzerland
[3] Roche, Translat Med, Basel, Switzerland
[4] Roche, Basel, Switzerland
[5] Univ Calif Los Angeles, Los Angeles, CA USA
[6] Emory Univ, Marcus Autism Ctr, Atlanta, GA 30322 USA
[7] Yale Univ, Ctr Child Study, New Haven, CT 06520 USA
来源：
BIOLOGICAL PSYCHIATRY | 2014年 / 75卷 / 09期
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
1159
引用
收藏
页码：324S / 325S
页数：2
相关论文
共 36 条
  • [1] Clinical and Biomarker Effects of a Novel Vasopressin 1a Receptor Antagonist (RG7713) vs. Placebo in High Functioning Adult Autism
    Hollander, Eric
    del Valle Rubido, Marta
    Khwaja, Omar
    Squassante, Lisa
    Ferretti, Casara Jean
    Taylor, Bonnie P.
    Berlin, Greg
    Noone, Rachel
    Antar, Laura
    Boak, Lauren
    Fontoura, Paulo
    McCracken, James
    Scahill, Larry
    Shic, Frederick
    Umbricht, Daniel
    NEUROPSYCHOPHARMACOLOGY, 2014, 39 : S374 - S375
  • [2] Treating head injury using a novel vasopressin 1a receptor antagonist
    Morrison, Thomas R.
    Kulkarni, Praveen
    Cai, Xuezhu
    Iriah, Sade
    Aggarwal, Dipak
    Lu, Shi-Fang
    Simon, Neal G.
    Madularu, Dan
    Ferrisa, Craig F.
    NEUROSCIENCE LETTERS, 2020, 714
  • [3] Discovery of RG7314: A vasopressin 1a receptor antagonist for the treatment of social communication deficits in autism spectrum disorders
    Schnider, Patrick
    Biemans, Barbara
    Bissantz, Caterina
    Dolente, Cosimo
    Goetschi, Erwin
    Jakob-Roetne, Roland
    Muster, Wolfgang
    Parrott, Neil
    Pinard, Emmanuel
    Ratni, Hasane
    Risterucci, Celine
    Rogers-Evans, Mark
    Schmitt, Monique
    Grundschober, Christophe
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254
  • [4] Results from a phase I proof-of-mechanism study with a vasopressin 1A receptor antagonist in autism spectrum disorder
    Rubido, M. Del Valle
    Umbricht, D.
    Shic, F.
    McCracken, J. T.
    Scahill, L.
    Khwaja, O.
    Squassante, L.
    Boak, L.
    Bolognani, F.
    Fontoura, P.
    Wall, C.
    Jou, R.
    Loomis, R.
    Lyons, M.
    Gavaletz, A.
    Cowen, J.
    Apelian, T.
    Jeste, S.
    Ferretti, C.
    Taylor, B.
    Berlin, G.
    Noone, R.
    Antar, L.
    Hollander, E.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S646 - S647
  • [5] Association Testing of Vasopressin Receptor 1a Microsatellite Polymorphisms in Non-Clinical Autism Spectrum Phenotypes
    Procyshyn, Tanya L.
    Hurd, Peter L.
    Crespi, Bernard J.
    AUTISM RESEARCH, 2017, 10 (05) : 750 - 756
  • [6] Effects of SRX246, a Vasopressin 1a Receptor (V1a) Antagonist, on an Experimental Model of Phasic and Sustained Threat in Humans
    Lago, Tiffany
    Brownstein, Michael
    Beydler, Emily
    Manbeck, Adrienne
    Beale, Alexis
    Simon, Neal
    Ernst, Monique
    Grillon, Christian
    BIOLOGICAL PSYCHIATRY, 2020, 87 (09) : S167 - S168
  • [7] Irritability in Huntington's Disease: A Phase 2 Exploratory Clinical Trial With a Novel Vasopressin 1a Antagonist, SRX246
    Simon, Neal
    Hersch, Steven
    Anderson, Karen
    Long, Jeff
    Ecklund, Dixie
    Costigan, Michele
    Thornell, Brenda
    Gladden, Catherine
    Coffey, Christopher
    Cudkowicz, Merit
    Brownstein, Michael
    NEUROPSYCHOPHARMACOLOGY, 2018, 43 : S421 - S421
  • [8] EFFECTS OF THE NOVEL 5-HT(1A) RECEPTOR ANTAGONIST, (+)-WAY-100135, ON STEREOTYPED BEHAVIOR INDUCED BY THE NMDA RECEPTOR ANTAGONIST DIZOCILPINE IN RATS
    LOSCHER, W
    HONACK, D
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 242 (01) : 99 - 104
  • [9] WAY 267,464, a non-peptide oxytocin receptor agonist, impairs social recognition memory in rats through a vasopressin 1A receptor antagonist action
    Hicks, Callum
    Ramos, Linnet
    Reekie, Tristan A.
    Narlawar, Rajeshwar
    Kassiou, Michael
    McGregor, Iain S.
    PSYCHOPHARMACOLOGY, 2015, 232 (15) : 2659 - 2667
  • [10] WAY 267,464, a non-peptide oxytocin receptor agonist, impairs social recognition memory in rats through a vasopressin 1A receptor antagonist action
    Callum Hicks
    Linnet Ramos
    Tristan A. Reekie
    Rajeshwar Narlawar
    Michael Kassiou
    Iain S. McGregor
    Psychopharmacology, 2015, 232 : 2659 - 2667
1234